1. Home
  2. FSBW vs VNDA Comparison

FSBW vs VNDA Comparison

Compare FSBW & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$43.51

Market Cap

312.7M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.10

Market Cap

441.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
VNDA
Founded
1936
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.7M
441.5M
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
FSBW
VNDA
Price
$43.51
$8.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$44.00
$13.63
AVG Volume (30 Days)
8.2K
2.8M
Earning Date
01-21-2026
02-12-2026
Dividend Yield
2.58%
N/A
EPS Growth
N/A
N/A
EPS
4.09
N/A
Revenue
$140,954,000.00
$212,074,000.00
Revenue This Year
$10.46
$12.01
Revenue Next Year
$4.42
$24.28
P/E Ratio
$10.62
N/A
Revenue Growth
1.07
11.12
52 Week Low
$34.61
$3.81
52 Week High
$44.22
$9.60

Technical Indicators

Market Signals
Indicator
FSBW
VNDA
Relative Strength Index (RSI) 60.77 61.30
Support Level $41.21 $7.14
Resistance Level $42.26 $7.82
Average True Range (ATR) 0.82 0.44
MACD 0.14 -0.05
Stochastic Oscillator 89.47 62.09

Price Performance

Historical Comparison
FSBW
VNDA

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: